Abdominal and Pelvic MR Angiography

Magnetic Resonance Imaging Clinics of North America

Volumn 15, Issue 3, 2007, Pages 301-314

  Michaely, Henrik J ^a,b   Attenberger, Ulrike I ^b   Kramer, Harald ^b   Nael, Kambiz ^c   Reiser, Maximilian F ^b   Schoenberg, Stefan O ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOFOSVESET; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOTERIDOL; SHU 555 C; UNCLASSIFIED DRUG;

AORTA DISSECTING ANEURYSM; AORTA DISSECTION; ARTIFACT; BREATH HOLDING; CLINICAL PROTOCOL; CONTRAST TO NOISE RATIO; DIGITAL SUBTRACTION ANGIOGRAPHY; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MAGNETIC RESONANCE ANGIOGRAPHY; OBSERVER VARIATION; RESTENOSIS; REVIEW; SIGNAL NOISE RATIO; STEADY STATE;

ABDOMEN; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; PELVIS; PERIPHERAL VASCULAR DISEASES; RENAL ARTERY OBSTRUCTION; TIME FACTORS;

EID: 34548802392     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2007.06.001     Document Type: Review

References (61)

1. Leiner T. Magnetic resonance angiography of abdominal and lower extremity vasculature. Top Magn Reson Imaging 16 (2005) 21-66
2. Schoenberg S.O., Rieger J., Nittka M., et al. Renal MR angiography: current debates and developments in imaging of renal artery stenosis. Semin Ultrasound CT MR 24 (2003) 255-267
3. Michaely H.J., Dietrich O., Nael K., et al. MRA of abdominal vessels: technical advances. Eur Radiol 16 (2006) 1637-1650
4. Vosshenrich R., and Fischer U. Contrast-enhanced MR angiography of abdominal vessels: is there still a role for angiography?. Eur Radiol 12 (2002) 218-230
5. Hoogeveen R.M., Bakker C.J., and Viergever M.A. Limits to the accuracy of vessel diameter measurement in MR angiography. J Magn Reson Imaging 8 (1998) 1228-1235
6. Vasbinder G.B.C., Maki J.H., Nijenhuis R.J., et al. Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. J Magn Reson Imaging 16 (2002) 685-696
7. Michaely H.J., Herrmann K.A., Kramer H., et al. High-resolution renal MRA: comparison of image quality and vessel depiction with different parallel imaging acceleration factors. J Magn Reson Imaging 24 (2006) 95-100
8. Schoenberg S.O., Rieger J., Weber C.H., et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology 235 (2005) 687-698
9. Campeau N.G., Huston III J., Bernstein M.A., et al. Magnetic resonance angiography at 3.0 Tesla: initial clinical experience. Top Magn Reson Imaging 12 (2001) 183-204
10. Merkle E.M., Dale B.M., and Paulson E.K. Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 14 (2006) 17-26
11. de Bazelaire C.M., Duhamel G.D., Rofsky N.M., et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 230 (2004) 652-659
12. Rohrer M., Bauer H., Mintorovitch J., et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40 (2005) 715-724
13. Schoenberg S.O., Knopp M.V., Londy F., et al. Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study. J Am Soc Nephrol 13 (2002) 158-169
14. Michaely H.J., Schoenberg S.O., Oesingmann N., et al. Renal artery stenosis: functional assessment with dynamic mr perfusion measurements-feasibility study. Radiology 238 (2006) 586-596
15. Merkle E.M., and Dale B.M. Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186 (2006) 1524-1532
16. Michaely H.J., Nael K., Schoenberg S.O., et al. The feasibility of spatial high-resolution magnetic resonance angiography (MRA) of the renal arteries at 3.0 T. Rofo 177 (2005) 800-804
17. Griswold M.A., Jakob P.M., Heidemann R.M., et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 47 (2002) 1202-1210
18. Pruessmann K.P., Weiger M., Scheidegger M.B., et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 42 (1999) 952-962
19. Fenchel M., Nael K., Deshpande V.S., et al. Renal magnetic resonance angiography at 3.0 Tesla using a 32-element phased-array coil system and parallel imaging in 2 directions. Invest Radiol 41 (2006) 697-703
20. Ho L.M., Merkle E.M., Paulson E.K., et al. Contrast-enhanced hepatic magnetic resonance angiography at 3 T: does parallel imaging improve image quality?. J Comput Assist Tomogr 31 (2007) 177-180
21. Huppertz A., and Rohrer M. Gadobutrol, a highly concentrated MR-imaging contrast agent: its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging. Eur Radiol 14 Suppl 5 (2004) M12-M18
22. Tombach B., and Heindel W. Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol 12 (2002) 1550-1556
23. Goyen M., Herborn C.U., Vogt F.M., et al. Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience. J Magn Reson Imaging 17 (2003) 565-571
24. Herborn C.U., Lauenstein T.C., Ruehm S.G., et al. Intraindividual comparison of gadopentetate dimeglumine, gadobenate dimeglumine, and gadobutrol for pelvic 3D magnetic resonance angiography. Invest Radiol 38 (2003) 27-33
25. Wikstrom J., Wasser M.N., Pattynama P.M., et al. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol 38 (2003) 504-515
26. Goyen M., and Debatin J.F. Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature. Eur Radiol 13 Suppl 3 (2003) N19-N27
27. Goyen M., Edelman M., Perreault P., et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236 (2005) 825-833
28. Michaely H.J., Herrmann K.A., Nael K., et al. Functional renal imaging: nonvascular renal disease. Abdom Imaging 32 (2007) 1-16
29. Michaely HJ, Kramer H, Lodemann KP, et al. Renal MRA at 3.0T with 0.1 mmol/kg gadolinium-interindividual comparision to renal MRA at 1.5 T with full dose of gadolinium. Presented at the Annual Conference of the International Society for Magnetic Resonance in Medicine. Berlin (Germany), 2007.
30. Herborn C, Watkins D, Runge V, et al. Effect of dose bisection at 3.0T on contrast-enhanced magnetic resonance angiography of the renal arteries. In Proceedings 13th Scientific Meeting, International Society for Magnetic Resonance in Medicine. Seattle (WA);2006. p. 512.
31. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 (2006) 1104-1108
32. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 (2007) 148-157
33. Broome D.R., Girguls M.S., and Baron P.W. Gadodlamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR AM J Roontgenol 188 (2007) 586-592
34. Safian R.D., and Textor S.C. Renal-artery stenosis. N Engl J Med 344 (2001) 431-442
35. Klatte E.C., Worrell J.A., Forster J.H., et al. Diagnostic criteria of bilateral renovascular hypertension. Radiology 101 (1971) 301-304
36. Sawicki P.T., Kaiser S., Heinemann L., et al. Prevalence of renal artery stenosis in diabetes mellitus-an autopsy study. J Intern Med 229 (1991) 489-492
37. Rihal C.S., Textor S.C., Breen J.F., et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 77 (2002) 309-316
38. Harding M.B., Smith L.R., Himmelstein S.I., et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 2 (1992) 608-616
39. Olin J.W., Melia M., Young J.R., et al. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88 (1990) 46N-51N
40. Wachtell K., Ibsen H., Olsen M.H., et al. Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension. J Hum Hypertens 10 (1996) 83-85
41. Textor S.C. Epidemiology and clinical presentation. Semin Nephrol 20 (2000) 426-431
42. Scoble J.E., and Hamilton G. Atherosclerotic renovascular disease. BMJ 300 (1990) 1670-1671
43. Slovut D.P., and Olin J.W. Fibromuscular dysplasia. N Engl J Med 350 (2004) 1862-1871
44. Thornton J., O'Callaghan J., Walshe J., et al. Comparison of digital subtraction angiography with gadolinium-enhanced magnetic resonance angiography in the diagnosis of renal artery stenosis. Eur Radiol 9 (1999) 930-934
45. Leung D.A., Hoffmann U., Pfammatter T., et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension 33 (1999) 726-731
46. Wasser M.N., Westenberg J., van der Hulst V.P., et al. Hemodynamic significance of renal artery stenosis: digital subtraction angiography versus systolically gated three-dimensional phase-contrast MR angiography. Radiology 202 (1997) 333
47. Tan K.T., van Beek E.J., Brown P.W., et al. Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 57 (2002) 617
48. Vasbinder G.B., Nelemans P.J., Kessels A.G., et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 141 (2004) 674
49. Kramer U., Nael K., Laub G., et al. High-resolution magnetic resonance angiography of the renal arteries using parallel imaging acquisition techniques at 3.0 T: initial experience. Invest Radiol 41 (2006) 125
50. Li L.P., Vu A.T., Li B.S., et al. Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T. J Magn Reson Imaging 20 (2004) 901
51. Michaely H.J., Kramer H., Oesingmann N., et al. Intraindividual comparison of MR-renal perfusion imaging at 1.5 T and 3.0 T. Invest Radiol 42 (2007) 406
52. Michaely H.J., Schoenberg S.O., Rieger J.R., et al. MR angiography in patients with renal disease. Magn Reson Imaging Clin N Am 13 (2005) 131
53. Schoenberg S.O., Wunsch C., Knopp M.V., et al. Abdominal aortic aneurysm. Detection of multilevel vascular pathology by time-resolved multiphase 3D gadolinium MR angiography: initial report. Invest Radiol 34 (1999) 648
54. Cornelissen SA, Prokop M, Adriaensen ME, et al. Visualizing slow-flow endoleak after endovascular abdominal aortic aneurysm repair with the new blood pool agent Vasovist. In Proceedings of the International Society for Magnetic Resonance in Medicine, Berlin (Germany).
55. Ruehm S.G. MR venography. Eur Radiol 13 (2003) 229
56. Edelman R.R., Storey P., Dunkle E., et al. Gadolinium-enhanced off-resonance contrast angiography. Magn Reson Med 57 (2007) 475
57. Edelman R, Li W, Dunkle E, et al. Scoutless abdominal angiography at 3 Tesla with two-dimensional acceleration. In Proceedings 13th Scientific Meeting, International Society for Magnetic Resonance in Medicine. Seattle (WA), p. 1930.
58. Reeder S.B., Hargreaves B.A., Yu H., et al. Homodyne reconstruction and IDEAL water-fat decomposition. Magn Reson Med 54 (2005) 586
59. Reeder S.B., McKenzie C.A., Pineda A.R., et al. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 25 (2007) 644
60. Spuentrup E., Buecker A., Meyer J., et al. Navigator-gated free-breathing 3D balanced FFE projection renal MRA: comparison with contrast-enhanced breath-hold 3D MRA in a swine model. Magn Reson Med 48 (2002) 739
61. Hilfiker P.R., Weishaupt D., Kacl G.M., et al. Comparison of three dimensional magnetic resonance imaging in conjunction with a blood pool contrast agent and nuclear scintigraphy for the detection of experimentally induced gastrointestinal bleeding. Gut 45 (1999) 581